Page last updated: 2024-10-30

mepivacaine and Peripheral Arterial Disease

mepivacaine has been researched along with Peripheral Arterial Disease in 1 studies

Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.

Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hysi, I1
Carjaliu, I1
Rebet, O1
Radutoiu, M1
PĂ©cheux, M1
Fabre, O1

Other Studies

1 other study available for mepivacaine and Peripheral Arterial Disease

ArticleYear
Axillary TAVR under locoregional anesthesia in a patient with peripheral artery disease.
    Multimedia manual of cardiothoracic surgery : MMCTS, 2020, Jun-10, Volume: 2020

    Topics: Aged, 80 and over; Anesthetics, Local; Aortic Valve Stenosis; Axilla; Brachial Plexus Block; Humans;

2020